Indeed, we and others have previously shown that pharmacological blockade of the CB1R in vivo increases thermogenic BAT activity (12) and consequently attenuates dyslipidemia and protects from diet-induced obesity in mice (12, 13, 14). This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.